SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Clinical trial NCT05731518 · UNKNOWN
Trial details
- NCT number
- NCT05731518
- Sponsor
- Biocity Biopharmaceutics Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-23
- Primary completion
- 2025-09-30
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.